INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2001

Dietary methionine restriction appears safe, feasible, and shows preliminary antitumor activity in advanced cancer.

This review discusses dietary restriction of methionine as a potential strategy for advanced cancer. Preclinical work led to a phase I clinical trial in adults with advanced cancer, where preliminary findings indicated the diet is safe and feasible. The trial also produced preliminary evidence of antitumor activity, including a 25% drop in serum PSA after 12 weeks in a patient with hormone-independent prostate cancer and an objective radiographic response in a patient with renal cell cancer.

Study type
Narrative review with phase I trial results
Who was studied
Adults with advanced cancer (including specific cases mentioned)
What was measured
Safety, feasibility, and preliminary antitumor activity (e.g., PSA levels, radiographic response)

THE PAPER

Can dietary methionine restriction increase the effectiveness of chemotherapy in treatment of advanced cancer?

Epner DE. J Am Coll Nutr, 2001.

PubMed 11603655 ↗DOI 10.1080/07315724.2001.10719183 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.